Cargando…
Tau positron emission tomography in patients with cognitive impairment and suspected Alzheimer’s disease
Alzheimer’s disease (AD) is diagnosed by the presence of both amyloid β and tau proteins. Recent advances in molecular PET imaging have made it possible to assess the accumulation of these proteins in the living brain. PET ligands have been developed that bind to 3R/4R tau in AD, but not to 3R tau o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Fukushima Society of Medical Science
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10480511/ https://www.ncbi.nlm.nih.gov/pubmed/37302841 http://dx.doi.org/10.5387/fms.2023-08 |